Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients.

Ruiz A, Nomdedeu M, Ortega M, Lejeune M, Setoain J, Climent N, Fumero E, Plana M, León A, Alós L, Piera C, Lomeña F, Gatell JM, Gallart T, García F.

Immunotherapy. 2009 May;1(3):347-54. doi: 10.2217/imt.09.5.

PMID:
20635955
2.

Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells.

Aarntzen EH, Srinivas M, Bonetto F, Cruz LJ, Verdijk P, Schreibelt G, van de Rakt M, Lesterhuis WJ, van Riel M, Punt CJ, Adema GJ, Heerschap A, Figdor CG, Oyen WJ, de Vries IJ.

Clin Cancer Res. 2013 Mar 15;19(6):1525-33. doi: 10.1158/1078-0432.CCR-12-1879. Epub 2013 Feb 4.

3.

111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content.

Blocklet D, Toungouz M, Kiss R, Lambermont M, Velu T, Duriau D, Goldman M, Goldman S.

Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):440-7.

PMID:
12722741
4.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
5.

Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial.

Ide F, Nakamura T, Tomizawa M, Kawana-Tachikawa A, Odawara T, Hosoya N, Iwamoto A.

J Med Virol. 2006 Jun;78(6):711-8.

PMID:
16628588
6.
7.

In vivo tracking of dendritic cells in patients with multiple myeloma.

Prince HM, Wall DM, Ritchie D, Honemann D, Harrrison S, Quach H, Thompson M, Hicks R, Lau E, Davison J, Loudovaris M, Moloney J, Loveland B, Bartholeyns J, Katsifis A, Mileshkin L.

J Immunother. 2008 Feb-Mar;31(2):166-79. doi: 10.1097/CJI.0b013e31815c5153.

PMID:
18481386
8.

CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.

Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F.

J Immunol. 2000 Mar 15;164(6):3095-101.

9.

Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.

Schaft N, Dörrie J, Thumann P, Beck VE, Müller I, Schultz ES, Kämpgen E, Dieckmann D, Schuler G.

J Immunol. 2005 Mar 1;174(5):3087-97. Erratum in: J Immunol. 2005 May 1;174(9):5884.

10.

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.

Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R.

J Immunol. 2003 Dec 1;171(11):5940-7.

11.

Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines.

Barratt-Boyes SM, Zimmer MI, Harshyne LA, Meyer EM, Watkins SC, Capuano S 3rd, Murphey-Corb M, Falo LD Jr, Donnenberg AD.

J Immunol. 2000 Mar 1;164(5):2487-95.

12.
13.

Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.

Climent N, Guerra S, García F, Rovira C, Miralles L, Gómez CE, Piqué N, Gil C, Gatell JM, Esteban M, Gallart T.

PLoS One. 2011;6(5):e19644. doi: 10.1371/journal.pone.0019644. Epub 2011 May 18.

14.

Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.

Cobb A, Roberts LK, Palucka AK, Mead H, Montes M, Ranganathan R, Burkeholder S, Finholt JP, Blankenship D, King B, Sloan L, Harrod AC, Lévy Y, Banchereau J.

J Immunol Methods. 2011 Feb 28;365(1-2):27-37. doi: 10.1016/j.jim.2010.11.002. Epub 2010 Nov 18.

PMID:
21093448
15.

Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.

Carbonneil C, Aouba A, Burgard M, Cardinaud S, Rouzioux C, Langlade-Demoyen P, Weiss L.

AIDS. 2003 Aug 15;17(12):1731-40.

PMID:
12891059
16.

Migration patterns of dendritic cells in the rat: comparison of the effects of gamma and UV-B irradiation on the migration of dendritic cells and Lymphocytes.

Oluwole SF, Engelstad K, De Rosa C, Wang TS, Fawwaz RA, Reemtsma K, Hardy MA.

Cell Immunol. 1991 Apr 1;133(2):390-407.

PMID:
2015631
17.

Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.

Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM, Strijk S, Eijckeler F, Bonenkamp JJ, Jacobs JF, Blokx W, Vankrieken JH, Joosten I, Boerman OC, Oyen WJ, Adema G, Punt CJ, Figdor CG, de Vries IJ.

Clin Cancer Res. 2009 Apr 1;15(7):2531-40. doi: 10.1158/1078-0432.CCR-08-2729. Epub 2009 Mar 24.

18.

Biodistribution of radiolabelled human dendritic cells injected by various routes.

Quillien V, Moisan A, Carsin A, Lesimple T, Lefeuvre C, Adamski H, Bertho N, Devillers A, Leberre C, Toujas L.

Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):731-41.

PMID:
15924229
19.

NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.

Ge MQ, Ho AW, Tang Y, Wong KH, Chua BY, Gasser S, Kemeny DM.

J Immunol. 2012 Sep 1;189(5):2099-109. doi: 10.4049/jimmunol.1103474. Epub 2012 Aug 6.

Supplemental Content

Support Center